Deutsche Bank’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Buy |
445,526
+90,433
| +25% | +$3.9M | 0.01% | 845 |
|
|
2025
Q1 | $12.3M | Buy |
355,093
+78,248
| +28% | +$2.71M | ﹤0.01% | 951 |
|
|
2024
Q4 | $7.6M | Sell |
276,845
-20,236
| -7% | -$555K | ﹤0.01% | 1132 |
|
|
2024
Q3 | $7.56M | Buy |
297,081
+18,850
| +7% | +$480K | ﹤0.01% | 1108 |
|
|
2024
Q2 | $7.05M | Sell |
278,231
-51,978
| -16% | -$1.32M | ﹤0.01% | 1102 |
|
|
2024
Q1 | $10.2M | Buy |
330,209
+84,156
| +34% | +$2.6M | ﹤0.01% | 1002 |
|
|
2023
Q4 | $9.93M | Buy |
246,053
+44,777
| +22% | +$1.81M | 0.01% | 994 |
|
|
2023
Q3 | $5.31M | Sell |
201,276
-71,001
| -26% | -$1.87M | ﹤0.01% | 1009 |
|
|
2023
Q2 | $4.68M | Sell |
272,277
-115,809
| -30% | -$1.99M | ﹤0.01% | 1265 |
|
|
2023
Q1 | $6.43M | Buy |
388,086
+101,938
| +36% | +$1.69M | ﹤0.01% | 1125 |
|
|
2022
Q4 | $2.18M | Buy |
286,148
+96,114
| +51% | +$732K | ﹤0.01% | 1611 |
|
|
2022
Q3 | $1.89M | Buy |
190,034
+82,139
| +76% | +$816K | ﹤0.01% | 1651 |
|
|
2022
Q2 | $979K | Buy |
107,895
+42,729
| +66% | +$388K | ﹤0.01% | 2193 |
|
|
2022
Q1 | $662K | Sell |
65,166
-4,423
| -6% | -$44.9K | ﹤0.01% | 2573 |
|
|
2021
Q4 | $1.16M | Sell |
69,589
-14,722
| -17% | -$246K | ﹤0.01% | 2329 |
|
|
2021
Q3 | $3.95M | Sell |
84,311
-242,751
| -74% | -$11.4M | ﹤0.01% | 1642 |
|
|
2021
Q2 | $19.9M | Sell |
327,062
-199,698
| -38% | -$12.2M | 0.01% | 900 |
|
|
2021
Q1 | $32.4M | Buy |
526,760
+472,390
| +869% | +$29.1M | 0.02% | 728 |
|
|
2020
Q4 | $3.87M | Buy |
54,370
+14,585
| +37% | +$1.04M | ﹤0.01% | 1490 |
|
|
2020
Q3 | $1.49M | Sell |
39,785
-2,171
| -5% | -$81.5K | ﹤0.01% | 1916 |
|
|
2020
Q2 | $1.37M | Buy |
41,956
+15,903
| +61% | +$519K | ﹤0.01% | 2017 |
|
|
2020
Q1 | $755K | Buy |
26,053
+17,952
| +222% | +$520K | ﹤0.01% | 2243 |
|
|
2019
Q4 | $283K | Buy |
8,101
+1,574
| +24% | +$55K | ﹤0.01% | 2993 |
|
|
2019
Q3 | $138K | Buy |
+6,527
| New | +$138K | ﹤0.01% | 3333 |
|